136 related articles for article (PubMed ID: 9649096)
1. Fetal heart rate and nuchal translucency in detecting chromosomal abnormalities other than Down syndrome.
Martinez JM; Echevarría M; Borrell A; Puerto B; Ojuel J; Fortuny A
Obstet Gynecol; 1998 Jul; 92(1):68-71. PubMed ID: 9649096
[TBL] [Abstract][Full Text] [Related]
2. Combining nuchal translucency with umbilical Doppler velocimetry for detecting fetal trisomies in the first trimester of pregnancy.
Martinez JM; Borrell A; Antolin E; Puerto B; Casals E; Ojuel J; Fortuny A
Br J Obstet Gynaecol; 1997 Jan; 104(1):11-4. PubMed ID: 8988688
[TBL] [Abstract][Full Text] [Related]
3. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
[TBL] [Abstract][Full Text] [Related]
5. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
Hyett JA; Noble PL; Snijders RJ; Montenegro N; Nicolaides KH
Ultrasound Obstet Gynecol; 1996 Apr; 7(4):239-44. PubMed ID: 8726874
[TBL] [Abstract][Full Text] [Related]
6. Fetal heart rate patterns in pregnancies with chromosomal disorders or subsequent fetal loss.
Martinez JM; Comas C; Ojuel J; Borrell A; Puerto B; Fortuny A
Obstet Gynecol; 1996 Jan; 87(1):118-21. PubMed ID: 8532245
[TBL] [Abstract][Full Text] [Related]
7. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
[TBL] [Abstract][Full Text] [Related]
8. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
9. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
[TBL] [Abstract][Full Text] [Related]
10. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
[TBL] [Abstract][Full Text] [Related]
11. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
[TBL] [Abstract][Full Text] [Related]
12. Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?
Comas C; Torrents M; Muñoz A; Antolín E; Figueras F; Echevarría M
Obstet Gynecol; 2002 Oct; 100(4):648-54. PubMed ID: 12383528
[TBL] [Abstract][Full Text] [Related]
13. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
Nicolaides KH; Brizot ML; Snijders RJ
Br J Obstet Gynaecol; 1994 Sep; 101(9):782-6. PubMed ID: 7947527
[TBL] [Abstract][Full Text] [Related]
14. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
15. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ; Snijders RJ; Hughes K; Sepulveda W; Nicolaides KH
Br J Obstet Gynaecol; 1996 Oct; 103(10):999-1003. PubMed ID: 8863698
[TBL] [Abstract][Full Text] [Related]
16. [Nuchal translucency: screening for chromosomal abnormalities and congenital malformations. Multicenter study].
Jemmali M; Valat AS; Poulain P; Favre R; Bourgeot P; Subtil D; Puech F
J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):538-43. PubMed ID: 10598347
[TBL] [Abstract][Full Text] [Related]
17. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
18. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
[TBL] [Abstract][Full Text] [Related]
19. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
20. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
